the unmet need our approach pipeline press gelesis in the news press releases careers contact us transforming the way we treat obesity and diabetes . gelesis is a biotechnology company developing a novel category of therapies to safely induce weight loss and improve glycemic control in overweight and obese patients . learn more facing a growing epidemic tackling obesity differently experienced team of leaders gelesis100 our lead product is a first in class therapeutic which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger resulting in reduced caloric intake and weight loss . gelesis100 is administered orally as a capsulated device . the unmet need our approach about us pipeline press contact us terms & conditions privacy policy 2016 gelesis . all rights reserved . www.gelesis100.com